tazobactam has been researched along with Chronic Bullous Disease of Childhood in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azcarraga-Llobet, C; Berna-Rico, ED; Bueno-Sacristan, D; de Nicolas-Ruanes, MB; Dominguez-Santas, M; Garcia-Mouronte, E; Moreno Garcia-Del Real, C | 1 |
| Akiyama, M; Hasegawa, H; Hashimoto, T; Ishii, N; Kato, Y; Ozawa, H; Tomida, E | 1 |
2 other study(ies) available for tazobactam and Chronic Bullous Disease of Childhood
| Article | Year |
|---|---|
Linear IgA bullous dermatosis secondary to piperacillin-tazobactam.
Topics: Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Piperacillin; Tazobactam | 2022 |
Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Drug Combinations; Drug Eruptions; Female; Humans; Linear IgA Bullous Dermatosis; Lymphocyte Activation; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2016 |